Building Cognitive Computing for Healthcare

Size: px
Start display at page:

Download "Building Cognitive Computing for Healthcare"

Transcription

1 Building Cognitive Computing for Healthcare Boston University Digital Health Initiative Round Table February 27 th 2017 Patrick McNeillie M.D. Clinical Lead and Senior Architect on Watson for Genomics

2 Agenda Building Cognitive Computing -Defining the Importance of Natural Language Processing (NLP) Applying Cognitive to a Complex Problem Surfacing Valuable Insights in Big Data

3 Moving Beyond Jeopardy: Bringing Cognitive Computing to Healthcare

4 Applying Cognitive Computing to Complex Problems Define Attributes Attribute Extraction Compare to Prior Knowledge Clinical Expert What is the best treatment for a given patient? Stage Stage IIIA IIIA Squamous Cell Squamous Cell Lung Cancer Lung Cancer PD-L1 Receptor PD-L1 Receptor Data Set

5 Applying Cognitive Computing to Complex Problems Define Attributes Attribute Extraction Compare to Prior Knowledge Clinical Expert What is the best treatment for a given patient? Stage Stage IIIA IIIA Squamous Cell Squamous Cell Lung Cancer Lung Cancer PD-L1 Receptor PD-L1 Receptor Stage IIIA PD-L1 Receptor Natural Language Processing Lung Cancer Squamous Cell Data Set

6 Applying Cognitive Computing to Complex Problems Define Attributes Attribute Extraction Compare to Prior Knowledge Clinical Expert What is the best treatment for a given patient? Stage Stage IIIA IIIA Squamous Cell Squamous Cell Lung Cancer Lung Cancer PD-L1 Receptor PD-L1 Receptor Stage IIIA PD-L1 Receptor Natural Language Processing Lung Cancer Squamous Cell Stage IIIA PD-L1 Receptor Atezolizumab Lung Cancer Treatment Squamous Cell Docetaxel Survival: 13.8 Months Survival: 9.6 Months Data Set

7 Applying Cognitive Computing to Complex Problems Define Attributes Attribute Extraction Compare to Prior Knowledge Clinical Expert What is the best treatment for a given patient? Stage Stage IIIA IIIA Squamous Cell Squamous Cell Lung Cancer Lung Cancer PD-L1 Receptor PD-L1 Receptor Stage IIIA PD-L1 Receptor Natural Language Processing Lung Cancer Squamous Cell Stage Stage Squamous Squamous IIIA IIIA Cell Cell Lung Lung Cancer Cancer PD-L1 PD-L1 Receptor Receptor Treatment?? Atezolizumab Docetaxel Survival: 13.8 Months Survival: 9.6 Months Data Set

8 Differences in attribute extraction between Machine Learning and Rules-Based NLP Machine Learning NLP Rules-Based NLP Rule: connect disease to therapy if within 10 words of each other nephrotic syndrome glomerulosclerosis >10 word <10 word <none> cortisol Disease Therapy steroid resistant nephrotic syndrome <subtype> glomerulosclerosis rxdx-101 Disease Therapy <conflict> nephrotic syndrome <conflict> glomerulosclerosis <incorrect> cortisol

9 Applying Cognitive to Genomics

10 Impact on Medical Genomics [COSMIC. Wellcome Trust Sanger Institute. October 2015 ] [Modern Pathology Mar;25(3): (accessed 10/5/2015)]

11 What s the best treatment given a tumor sequence?

12 Ingest & Learn Reference Genomes Molecular Protein Pathways Genomic Databases Clinical Partners (currently 16 centers) Unstructured Text Best Practices Guidelines Patient Data Literature Articles Clinical Trials Conference Reports Process Patient Data Output Report Personalized Driver Alterations and Targeted Therapies

13 Our Approach to NLP Boston University Digital Health Initiative Round Table Focused Annotation Specialist Team (FAST) NLP Expert Annotator Label Documents Standardize Ontologies and Dictionaries Train Machine Learning Measure Performance 1.00 Enable Integration & Reuse Reduce Bias

14 Annotating mentions Boston University Digital Health Initiative Round Table 2014 International Business Machines Corporation 14

15 Annotating relationships Boston University Digital Health Initiative Round Table 2014 International Business Machines Corporation 15

16 Ensuring Agreement: Measuring Kappa Scores 100% Agreement Domain Experts Annotators Time

17 Concepts Detection: Compare to a standard and iterate Boston University Digital Health Initiative Round Table Model Performance for Labeling Concepts When a plateau is reached, development teams need to assess if the plateau is secondary to bias or variance to efficiently apply resources and iterate F1 Precision Recall

18 Relationship Detection: Compare to a standard and iterate Model Performance for Labeling Relationships When a plateau is reached, development teams need to assess if the plateau is secondary to bias or variance to efficiently apply resources and iterate F1 Precision Recall

19 Maintaining Context Within and Across Documents <text>unexpectedly, we find that EGFR A763_Y764insFQEA is highly sensitive to EGFR TKIs in vitro, and patients whose NSCLCs harbor this mutation respond to erlotinib.</text> ="alters"> <relation rid="s6-r1" subtype="other" type="alters"> <rel_entity_arg argnum="1" eid="e-39"/> <rel_entity_arg argnum="2" eid="c1"/> <relmentions> <relmention class="specific" modality="asserted" rmid="s6-r1-1" score="1" tense="unspecified"> <rel_mention_arg argnum="1" mid="s6-m6">a763_y764insfqea</rel_mention_arg> <rel_mention_arg argnum="2" mid="s6-m0">egfr</rel_mention_arg> <relation rid="s6-r5" subtype="other" type="drives"> <rel_entity_arg argnum="1" eid="c1"/> <rel_entity_arg argnum="2" eid="c3"/> <relmentions> <relmention class="specific" modality="asserted" rmid="s6-r5-1" score="1" tense="unspecified"> <rel_mention_arg argnum="1" mid="s6-m0">egfr</rel_mention_arg> Variant s6-m6 A763_Y764insFQEA type=category Rel: Alters PMID: Gene/Protein S6-m0 EGFR type=concept <rel_mention_arg argnum="2" mid="s6-m8">egfr TKIs</rel_mention_arg> Gene/Protein S6-m0 EGFR type=concept Rel: Sensitive PMID: Cancer Type S6-m8 EGFR TKIs type=concept

20 Clinical Knowledge: Example Graph

21 Boston University Digital Health Initiative Round Table Clinical Knowledge: Extracted Data from Corpus of Documents

22 Boston University Digital Health Initiative Round Table Clinical Knowledge: Extracted Data from Corpus of Documents

23 Output Sample from Knowledge Graph Query

24 Leveraging Literature Articles to Support Clinical Care

25 Leveraging Literature Articles to Support Clinical Care

26 Summary

27 Empowering Healthcare Professionals with Cognitive Computing The Process of Building Work Closely with domain experts Leverage tools (like NLP) to extract unstructured concepts and their associations Combine unstructured and structured data to create knowledge Value of Applying to Healthcare Increased efficiency Reduced bias Scaling expert knowledge Innovating across a complex domain Validate and iterate with domain experts With Cognitive computing, the extraction of information from clinical data and published literature can empower healthcare professionals to stay up-to-date, focus on the complex problems, and spend more time with caring for patients.

28 Questions? (remember, I m not Watson..)

How can Natural Language Processing help MedDRA coding? April Andrew Winter Ph.D., Senior Life Science Specialist, Linguamatics

How can Natural Language Processing help MedDRA coding? April Andrew Winter Ph.D., Senior Life Science Specialist, Linguamatics How can Natural Language Processing help MedDRA coding? April 16 2018 Andrew Winter Ph.D., Senior Life Science Specialist, Linguamatics Summary About NLP and NLP in life sciences Uses of NLP with MedDRA

More information

How Big Data and Advanced Analytics Can Improve Population Health: Now and In the Near Future

How Big Data and Advanced Analytics Can Improve Population Health: Now and In the Near Future How Big Data and Advanced Analytics Can Improve Population Health: Now and In the Near Future William J. Kassler, MD, MPH Deputy Chief Health Officer Lead Population Health Officer Precision Medicine Completion

More information

The Human Behaviour-Change Project

The Human Behaviour-Change Project The Human Behaviour-Change Project Participating organisations A Collaborative Award funded by the www.humanbehaviourchange.org @HBCProject This evening Opening remarks from the chair Mary de Silva, The

More information

Introduction to the Partners Biobank Portal. December 2016

Introduction to the Partners Biobank Portal. December 2016 Introduction to the Partners Biobank Portal December 2016 Agenda About the Partners Biobank About the Biobank Portal Data Types in the Biobank Sample types DNA. Plasma and Serum Consent Genomic Data Health

More information

Watson Summit Prague 2017

Watson Summit Prague 2017 Watson for Oncology Matěj Adam Watson Health Executive May 2017 Watson Summit Prague 2017 an IBM Company Leadership & 23 Years Patent Leadership Research Spend Global Presence Technology 7300+ 2015 $6B

More information

Using Natural Language Processing To Analyze Electronic Health Records. Philip Poon PhD Data Scientist

Using Natural Language Processing To Analyze Electronic Health Records. Philip Poon PhD Data Scientist Using Natural Language Processing To Analyze Electronic Health Records Philip Poon PhD Data Scientist Agenda Overview of UnityPoint Health and Electronic Health Record Natural Language Processing development

More information

NCCN TRENDS DEMOGRAPHICS. Results: November 2013 NON-SMALL CELL LUNG CANCER. Distribution of Respondent Types (n = 835) Page 1

NCCN TRENDS DEMOGRAPHICS. Results: November 2013 NON-SMALL CELL LUNG CANCER. Distribution of Respondent Types (n = 835) Page 1 NCCN TRENDS Results: November 2013 NCCN Trends is an analytics tool from the National Comprehensive Cancer Network (NCCN ) that surveys how clinicians across the U.S. and around the globe are delivering

More information

Infrastructure for Clinical Data Exchange

Infrastructure for Clinical Data Exchange Infrastructure for Clinical Data Exchange Amy Abernethy, MD, PhD FEBRUARY 29 2016 Instrument Data Highly Structured Administrative Data Highly Structured Clinical Research Data Intentionally Structured

More information

Boehringer Ingelheim Pharmaceuticals, Inc. & Univision. Making Diabetic Hispanics Healthier

Boehringer Ingelheim Pharmaceuticals, Inc. & Univision. Making Diabetic Hispanics Healthier Boehringer Ingelheim Pharmaceuticals, Inc. & Univision Making Diabetic Hispanics Healthier Agenda BIPI and the Hispanic segment Organizing and Executing to Win The Proof is in the Results Making Hispanics

More information

Knowledge networks of biological and medical data An exhaustive and flexible solution to model life sciences domains

Knowledge networks of biological and medical data An exhaustive and flexible solution to model life sciences domains Knowledge networks of biological and medical data An exhaustive and flexible solution to model life sciences domains Dr. Sascha Losko, Dr. Karsten Wenger, Dr. Wenzel Kalus, Dr. Andrea Ramge, Dr. Jens Wiehler,

More information

Clinical NLP, PubGene Clinical trials in Coremine Oncology Text processing and information extraction for surgery planning form

Clinical NLP, PubGene Clinical trials in Coremine Oncology Text processing and information extraction for surgery planning form Clinical NLP, PubGene Clinical trials in Coremine Oncology Text processing and information extraction for surgery planning form November 2017 Dag Are Steenhoff Hov, PubGene AS 1 PubGene, founded 2001 ArrayIt

More information

VeriStrat Poor Patients Show Encouraging Overall Survival and Progression Free Survival Signal; Confirmatory Phase 2 Study Planned by Year-End

VeriStrat Poor Patients Show Encouraging Overall Survival and Progression Free Survival Signal; Confirmatory Phase 2 Study Planned by Year-End AVEO and Biodesix Announce Exploratory Analysis of VeriStrat-Selected Patients with Non-Small Cell Lung Cancer in Phase 2 Study of Ficlatuzumab Presented at ESMO 2014 Congress VeriStrat Poor Patients Show

More information

Molecular Testing in Lung Cancer

Molecular Testing in Lung Cancer Molecular Testing in Lung Cancer Pimpin Incharoen, M.D. Assistant Professor, Thoracic Pathology Department of Pathology, Ramathibodi Hospital Genetic alterations in lung cancer Source: Khono et al, Trans

More information

Innovative Risk and Quality Solutions for Value-Based Care. Company Overview

Innovative Risk and Quality Solutions for Value-Based Care. Company Overview Innovative Risk and Quality Solutions for Value-Based Care Company Overview Meet Talix Talix provides risk and quality solutions to help providers, payers and accountable care organizations address the

More information

Looking for Subjectivity in Medical Discharge Summaries The Obesity NLP i2b2 Challenge (2008)

Looking for Subjectivity in Medical Discharge Summaries The Obesity NLP i2b2 Challenge (2008) Looking for Subjectivity in Medical Discharge Summaries The Obesity NLP i2b2 Challenge (2008) Michael Roylance and Nicholas Waltner Tuesday 3 rd June, 2014 Michael Roylance and Nicholas Waltner Looking

More information

REFERENCE CODE GDHC198DFR PUBLICAT ION DATE JUNE 2013 TARCEVA (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC198DFR PUBLICAT ION DATE JUNE 2013 TARCEVA (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC198DFR PUBLICAT ION DATE JUNE 2013 TARCEVA (NON-SMALL CELL LUNG CANCER) Executive Summary Tarceva (erlotinib): Key Metrics in NSCLC Markets 2012 Tarceva Sales US 5EU Japan China India

More information

Whole Genome and Transcriptome Analysis of Anaplastic Meningioma. Patrick Tarpey Cancer Genome Project Wellcome Trust Sanger Institute

Whole Genome and Transcriptome Analysis of Anaplastic Meningioma. Patrick Tarpey Cancer Genome Project Wellcome Trust Sanger Institute Whole Genome and Transcriptome Analysis of Anaplastic Meningioma Patrick Tarpey Cancer Genome Project Wellcome Trust Sanger Institute Outline Anaplastic meningioma compared to other cancers Whole genomes

More information

NAVIFY Tumor Board NAVIFY

NAVIFY Tumor Board NAVIFY NAVIFY Tumor Board Make the most informed personalized treatment decisions possible by leveraging innovative technologies and the latest scientific and clinical data WHAT S INSIDE Key Takeaways NAVIFY

More information

AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits

AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits Accelerating clinical research Next-generation sequencing (NGS) has the ability to interrogate many different genes and detect

More information

REFERENCE CODE GDHC199DFR PUBLICAT ION DATE JUNE 2013 XALKORI (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC199DFR PUBLICAT ION DATE JUNE 2013 XALKORI (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC199DFR PUBLICAT ION DATE JUNE 2013 XALKORI (NON-SMALL CELL LUNG CANCER) Executive Summary Xalkori (crizotinib): Key Metrics in NSCLC Markets 2012 Xalkori Sales US 5EU Japan China India

More information

REFERENCE CODE GDHC200DFR PUBLICAT ION DATE JUNE 2013 AVASTIN (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC200DFR PUBLICAT ION DATE JUNE 2013 AVASTIN (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC200DFR PUBLICAT ION DATE JUNE 2013 AVASTIN (NON-SMALL CELL LUNG CANCER) AVASTIN (NON-SMALL CELL LUNG CANCER) - Executive Summary Avastin (bevacizumab): Key Metrics in NSCLC Markets 2012

More information

THE ANALYTICS EDGE. Intelligence, Happiness, and Health x The Analytics Edge

THE ANALYTICS EDGE. Intelligence, Happiness, and Health x The Analytics Edge THE ANALYTICS EDGE Intelligence, Happiness, and Health 15.071x The Analytics Edge Data is Powerful and Everywhere 2.7 Zettabytes of electronic data exist in the world today 2,700,000,000,000,000,000,000

More information

Data Sharing Consortiums and Large Datasets to Inform Cancer Diagnosis

Data Sharing Consortiums and Large Datasets to Inform Cancer Diagnosis February, 13th 2018 Data Sharing Consortiums and Large Datasets to Inform Cancer Diagnosis Improving Cancer Diagnosis and Care: Patient Access to Oncologic Imaging and Pathology Expertise and Technologies:

More information

REFERENCE CODE GDHC207DFR PUBLICAT ION DATE JUNE 2013 GILOTRIF (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC207DFR PUBLICAT ION DATE JUNE 2013 GILOTRIF (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC207DFR PUBLICAT ION DATE JUNE 2013 GILOTRIF (NON-SMALL CELL LUNG CANCER) GILOTRIF (NON-SMALL CELL LUNG CANCER) - Executive Summary Gilotrif: Key Metrics in NSCLC Markets 2022 Gilotrif

More information

Text Mining of Patient Demographics and Diagnoses from Psychiatric Assessments

Text Mining of Patient Demographics and Diagnoses from Psychiatric Assessments University of Wisconsin Milwaukee UWM Digital Commons Theses and Dissertations December 2014 Text Mining of Patient Demographics and Diagnoses from Psychiatric Assessments Eric James Klosterman University

More information

REFERENCE CODE GDHC196DFR PUBLICAT ION DATE JUNE 2013 ABRAXANE (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC196DFR PUBLICAT ION DATE JUNE 2013 ABRAXANE (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC196DFR PUBLICAT ION DATE JUNE 2013 ABRAXANE (NON-SMALL CELL LUNG CANCER) Executive Summary Abraxane (nab-paclitaxel): Key Metrics in NSCLC Markets 2012 Abraxane Sales US 5EU $98.34m

More information

NCCN Non-Small Cell Lung Cancer V Meeting June 15, 2018

NCCN Non-Small Cell Lung Cancer V Meeting June 15, 2018 Guideline Page and Request Illumina Inc. requesting to replace Testing should be conducted as part of broad molecular profiling with Consider NGS-based assays that include EGFR, ALK, ROS1, and BRAF as

More information

StrandAdvantage Tissue-Specific Cancer Genomic Tests. Empowering Crucial First-Line Therapy Decisions for Your Patient

StrandAdvantage Tissue-Specific Cancer Genomic Tests. Empowering Crucial First-Line Therapy Decisions for Your Patient StrandAdvantage Tissue-Specific Cancer Genomic Tests Empowering Crucial First-Line Therapy Decisions for Your Patient Harness the power of precision medicine with StrandAdvantage Precision medicine in

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Molecular Analysis for Targeted Therapy for Non-Small Cell Lung File Name: Origination: Last CAP Review: Next CAP Review: Last Review: molecular_analysis_for_targeted_therapy_for_non_small_cell_lung_cancer

More information

From Population Health to Precision Health. William J, Kassler, MD, MPH Deputy Chief Health Officer March 28, 2017

From Population Health to Precision Health. William J, Kassler, MD, MPH Deputy Chief Health Officer March 28, 2017 From Population Health to Precision Health William J, Kassler, MD, MPH Deputy Chief Health Officer March 28, 2017 2 The current health system faces serious challenges. 3 A New Era of Personalized Healthcare

More information

How to Advance Beyond Regular Data with Text Analytics

How to Advance Beyond Regular Data with Text Analytics Session #34 How to Advance Beyond Regular Data with Text Analytics Mike Dow Director, Product Development, Health Catalyst Carolyn Wong Simpkins, MD, PhD Chief Medical Informatics Officer, Health Catalyst

More information

ALCHEMIST. Adjuvant Lung Cancer Enrichment Marker Identification And Sequencing Trials

ALCHEMIST. Adjuvant Lung Cancer Enrichment Marker Identification And Sequencing Trials ALCHEMIST Adjuvant Lung Cancer Enrichment Marker Identification And Sequencing Trials What is ALCHEMIST? ALCHEMIST is 3 integrated trials testing targeted therapy in early stage lung cancer: l A151216:

More information

What Smokers Who Switched to Vapor Products Tell Us About Themselves. Presented by Julie Woessner, J.D. CASAA National Policy Director

What Smokers Who Switched to Vapor Products Tell Us About Themselves. Presented by Julie Woessner, J.D. CASAA National Policy Director What Smokers Who Switched to Vapor Products Tell Us About Themselves Presented by Julie Woessner, J.D. CASAA National Policy Director The CASAA Consumer Testimonials Database Collection began in 2013 through

More information

Strategy Strategic delivery: Setting standards Increasing and informing choice. Details: Output: Demonstrating efficiency economy and value

Strategy Strategic delivery: Setting standards Increasing and informing choice. Details: Output: Demonstrating efficiency economy and value Strategy 2017-20 Strategic delivery: Setting standards Increasing and informing choice Demonstrating efficiency economy and value Details: Meeting Authority Agenda item 7 Paper number HFEA (11/05/2016)

More information

The 100,000 Genomes Project

The 100,000 Genomes Project The 100,000 Genomes Project Dr Matina Prapa, Scientific co ordinator Genomics England Clinical Interpretation Partnership William Harvey Research Institute Queen Mary University of London Genomics England

More information

COMMITMENT &SOLUTIONS UNPARALLELED. Assessing Human Visual Inspection for Acceptance Testing: An Attribute Agreement Analysis Case Study

COMMITMENT &SOLUTIONS UNPARALLELED. Assessing Human Visual Inspection for Acceptance Testing: An Attribute Agreement Analysis Case Study DATAWorks 2018 - March 21, 2018 Assessing Human Visual Inspection for Acceptance Testing: An Attribute Agreement Analysis Case Study Christopher Drake Lead Statistician, Small Caliber Munitions QE&SA Statistical

More information

Cardiac CT Course Part A First step towards level 2 SCCT registration

Cardiac CT Course Part A First step towards level 2 SCCT registration 29 September 2 October 2016 Philips Customer Education Center Business Central Towers, Dubai Internet City, Sheikh Zayed Road, Dubai, UAE The use of Multi-Detector CT (MDCT) in the diagnosis of various

More information

IMMUNOTHERAPY FOR LUNG CANCER

IMMUNOTHERAPY FOR LUNG CANCER IMMUNOTHERAPY FOR LUNG CANCER Patient and Caregiver Guide IMMUNOTHERAPY FOR LUNG CANCER Patient and Caregiver Guide TABLE OF CONTENTS Lung Cancer Basics... 2 Immunotherapy... 3 FDA Approved Immunotherapies...

More information

NWCDC 2018 Pharmacy Analytics in Workers Comp

NWCDC 2018 Pharmacy Analytics in Workers Comp NWCDC 2018 Pharmacy Analytics in Workers Comp Cliff Belliveau VP Business Intelligence What is Visual Analytics? Transforming data into insights that tell a story 2 A little history Jacquard loom Punch

More information

Establishing a Framework to Evaluate Real-World Endpoints

Establishing a Framework to Evaluate Real-World Endpoints Establishing a Framework to Evaluate Real-World Endpoints Introduction July 10, 2018 Washington, DC Advances in data analytics and data capture through electronic health records (EHRs) and medical/pharmacy

More information

immunotherapy a guide for the patient

immunotherapy a guide for the patient immunotherapy FOR LUNG CANCER a guide for the patient TABLE OF CONTENTS lung cancer basics... 2 immunotherapy... 5 Checkpoint Inhibitors... 6-9 Monoclonal Antibodies... 9 Vaccines... 10 Adoptive T-Cell

More information

Lung Cancer Concept Annotation from Spanish Clinical Narratives

Lung Cancer Concept Annotation from Spanish Clinical Narratives Lung Cancer Concept Annotation from Spanish Clinical Narratives Marjan Najafabadipour 1, [0000-0002-1428-9330], Juan Manuel Tuñas 1[0000-0001-8241-5602], Alejandro Rodríguez-González 1,2,* [0000-0001-8801-4762]

More information

OncoPPi Portal A Cancer Protein Interaction Network to Inform Therapeutic Strategies

OncoPPi Portal A Cancer Protein Interaction Network to Inform Therapeutic Strategies OncoPPi Portal A Cancer Protein Interaction Network to Inform Therapeutic Strategies 2017 Contents Datasets... 2 Protein-protein interaction dataset... 2 Set of known PPIs... 3 Domain-domain interactions...

More information

Where Are We Going: The Future of Cancer. Brenda Nevidjon, MSN, RN, FAAN Chief Executive Officer, ONS

Where Are We Going: The Future of Cancer. Brenda Nevidjon, MSN, RN, FAAN Chief Executive Officer, ONS Where Are We Going: The Future of Cancer Brenda Nevidjon, MSN, RN, FAAN Chief Executive Officer, ONS Imagine The future depends on what you do today. Mahatma Gandhi Cancer Today Globally, more deaths from

More information

ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE

ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE CATALYSTS DRIVING SUCCESSFUL DECISIONS IN LIFE SCIENCES ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE AT KANTAR HEALTH, ONCOLOGY

More information

Session 4 Rebecca Poulos

Session 4 Rebecca Poulos The Cancer Genome Atlas (TCGA) & International Cancer Genome Consortium (ICGC) Session 4 Rebecca Poulos Prince of Wales Clinical School Introductory bioinformatics for human genomics workshop, UNSW 20

More information

IBM Research Report. Automated Problem List Generation from Electronic Medical Records in IBM Watson

IBM Research Report. Automated Problem List Generation from Electronic Medical Records in IBM Watson RC25496 (WAT1409-068) September 24, 2014 Computer Science IBM Research Report Automated Problem List Generation from Electronic Medical Records in IBM Watson Murthy Devarakonda, Ching-Huei Tsou IBM Research

More information

PROSPERO International prospective register of systematic reviews

PROSPERO International prospective register of systematic reviews PROSPERO International prospective register of systematic reviews Meta-analysis of randomized controlled trials in first-line treatment of squamous non-small cell lung cancer Lisa Hess, Amy De Lozier,

More information

Three Rules for Measuring Physician Market Share

Three Rules for Measuring Physician Market Share Crimson Market Advantage RESEARCH BRIEFING Three Rules for Measuring Physician Market Share Research and insights Performance Technologies Consulting and management Talent Development new definition Hospitals

More information

Multi-modal Patient Cohort Identification from EEG Report and Signal Data

Multi-modal Patient Cohort Identification from EEG Report and Signal Data Multi-modal Patient Cohort Identification from EEG Report and Signal Data Travis R. Goodwin and Sanda M. Harabagiu The University of Texas at Dallas Human Language Technology Research Institute http://www.hlt.utdallas.edu

More information

Sound Off DR. GOOGLE S ROLE IN PRE-DIAGNOSIS THROUGH TREATMENT. Ipsos SMX. June 2014

Sound Off DR. GOOGLE S ROLE IN PRE-DIAGNOSIS THROUGH TREATMENT. Ipsos SMX. June 2014 Sound Off DR. GOOGLE S ROLE IN PRE-DIAGNOSIS THROUGH TREATMENT June 2014 Ipsos SMX : Sound bits (of advice) and bites (of research) from Ipsos SMX Ipsos social media research division, dedicated to providing

More information

Daniel Lieber, Ph.D. Senior Scientist, Computational Biology Foundation Medicine, Cambridge, MA. AACR 2017: Clinical Biomarkers April 3, 2017

Daniel Lieber, Ph.D. Senior Scientist, Computational Biology Foundation Medicine, Cambridge, MA. AACR 2017: Clinical Biomarkers April 3, 2017 Validation & clinical feasibility of a comprehensive genomic profiling assay to identify likely immunotherapy responders through tumor mutational burden (TMB) Daniel Lieber, Ph.D. Senior Scientist, Computational

More information

TIES Cancer Research Network Y2 Face to Face Meeting U24 CA October 29 th, 2014 University of Pennsylvania

TIES Cancer Research Network Y2 Face to Face Meeting U24 CA October 29 th, 2014 University of Pennsylvania TIES Cancer Research Network Y2 Face to Face Meeting U24 CA 180921 Session IV The Future of TIES October 29 th, 2014 University of Pennsylvania Afternoon Other Uses of TIES/Future of TIES 12:45-1:15 TIES

More information

Media Release. Basel, 07 December 2017

Media Release. Basel, 07 December 2017 Media Release Basel, 07 December 2017 Phase III IMpower150 study showed Tecentriq (atezolizumab) and Avastin (bevacizumab) plus chemotherapy reduced the risk of disease worsening or death by 38 percent

More information

Schema-Driven Relationship Extraction from Unstructured Text

Schema-Driven Relationship Extraction from Unstructured Text Wright State University CORE Scholar Kno.e.sis Publications The Ohio Center of Excellence in Knowledge- Enabled Computing (Kno.e.sis) 2007 Schema-Driven Relationship Extraction from Unstructured Text Cartic

More information

Identifying Novel Targets for Non-Small Cell Lung Cancer Just How Novel Are They?

Identifying Novel Targets for Non-Small Cell Lung Cancer Just How Novel Are They? Identifying Novel Targets for Non-Small Cell Lung Cancer Just How Novel Are They? Dubovenko Alexey Discovery Product Manager Sonia Novikova Solution Scientist September 2018 2 Non-Small Cell Lung Cancer

More information

The Curing AI for Precision Medicine. Hoifung Poon

The Curing AI for Precision Medicine. Hoifung Poon The Curing AI for Precision Medicine Hoifung Poon 1 Medicine Today Is Imprecise Top 20 drugs 80% non-responders Wasted 1/3 health spending $750 billion / year 2 Disruption 1: Big Data 2009 2013: 40% 93%

More information

33 rd Annual J.P. Morgan Healthcare Conference. January 2015

33 rd Annual J.P. Morgan Healthcare Conference. January 2015 33 rd Annual J.P. Morgan Healthcare Conference January 2015 Forward-looking Statements This presentation contains forward-looking statements, which express the current beliefs and expectations of management.

More information

Engaging People Strategy

Engaging People Strategy Engaging People Strategy 2014-2020 Author: Rosemary Hampson, Public Partnership Co-ordinator Executive Lead Officer: Richard Norris, Director, Scottish Health Council Last updated: September 2014 Status:

More information

Cardiac CT Course Part A First step towards level 2 SCCT registration

Cardiac CT Course Part A First step towards level 2 SCCT registration 20-23 May 2016 Philips Customer Education Center Business Central Towers, Dubai Internet City, Sheikh Zayed Road, Dubai, UAE The use of Multi-Detector CT (MDCT) in the diagnosis of various cardiac diseases

More information

Systems Thinking in Personalized Medicine

Systems Thinking in Personalized Medicine Systems Thinking in Personalized Medicine Devon C. Campbell Head, Engineering and Systems Novartis Molecular Diagnostics MIT SDM Systems Thinking Conference October 25, 2011 Agenda Personalized medicine

More information

Logistics of Alchemist Screening Trial A Shauna Hillman, Statistician Chelsea Schultz, Data Manager Alliance SDC

Logistics of Alchemist Screening Trial A Shauna Hillman, Statistician Chelsea Schultz, Data Manager Alliance SDC Logistics of Alchemist Screening Trial A151216 Shauna Hillman, Statistician Chelsea Schultz, Data Manager Alliance SDC Alliance Fall Meeting Nov, 2014 Presentation Objectives To Provide Background and

More information

An Introduction to Acute Kidney Injury (AKI) An Education Package for Healthcare Professionals in Medical Directorates

An Introduction to Acute Kidney Injury (AKI) An Education Package for Healthcare Professionals in Medical Directorates An Introduction to Acute Kidney Injury (AKI) An Education Package for Healthcare Professionals in Medical Directorates STH Acute Kidney Injury (AKI) Project 1 What is Acute Kidney Injury (AKI)? AKI is

More information

The Patient Journey Evolution

The Patient Journey Evolution The Patient Journey Evolution A Case Study Alex Zhu & Bill Salokar SKIM 1 Digital is transforming business and Healthcare is no exception 70% US consumers use a digital channel to manage health & wellness

More information

Bigomics : Challenges and promises in large scale sequencing projects

Bigomics : Challenges and promises in large scale sequencing projects Bigomics : Challenges and promises in large scale sequencing projects Theodore M. Wong Ken Yocum MSST 2014 2010 Illumina, Inc. All rights reserved. Illumina, illuminadx, Solexa, Making Sense Out of Life,

More information

BigMedilytics Big Data for Medical Analytics

BigMedilytics Big Data for Medical Analytics 01010010010100100100010101001 010100010100010 01010 10010010010001010 01010010010010010010010 0100100100010001001001001 BigMedilytics Big Data for Medical Analytics 001010010100101 1010010010001001001

More information

Predictive Analytics and machine learning in clinical decision systems: simplified medical management decision making for health practitioners

Predictive Analytics and machine learning in clinical decision systems: simplified medical management decision making for health practitioners Predictive Analytics and machine learning in clinical decision systems: simplified medical management decision making for health practitioners Mohamed Yassine, MD Vice President, Head of US Medical Affairs

More information

Memory-Augmented Active Deep Learning for Identifying Relations Between Distant Medical Concepts in Electroencephalography Reports

Memory-Augmented Active Deep Learning for Identifying Relations Between Distant Medical Concepts in Electroencephalography Reports Memory-Augmented Active Deep Learning for Identifying Relations Between Distant Medical Concepts in Electroencephalography Reports Ramon Maldonado, BS, Travis Goodwin, PhD Sanda M. Harabagiu, PhD The University

More information

NCCN TRENDS DEMOGRAPHICS. Results: January 2013 NON-SMALL CELL LUNG CANCER. Distribution of Respondent Types (n = 1,055) Page 1

NCCN TRENDS DEMOGRAPHICS. Results: January 2013 NON-SMALL CELL LUNG CANCER. Distribution of Respondent Types (n = 1,055) Page 1 NCCN TRENDS Results: January 2013 NCCN Trends is an analytics tool from the National Comprehensive Cancer Network (NCCN ) that surveys how clinicians across the U.S. and around the globe are delivering

More information

But How Do You Know It s Working?

But How Do You Know It s Working? But How Do You Know It s Working? Outcome Measurement and Evaluation MARY HANIFIN SENIOR MANAGING DIRECTOR, DEVELOPMENT MASSACHUSETTS GENERAL HOSPITAL LABRINI NELLIGAN EXECUTIVE DIRECTOR LUNDER- DINEEN

More information

212/ ; ;

212/ ; ; Contact: Diana Franco, Ballantine Tammy Richards-LeSure, Richards Public Relations 212/572-2533; dfranco@randomhouse.com 817-453-6166; richardspr@charter.net The Love Response Your Prescription to Turn

More information

Cognitive Health in the Workplace

Cognitive Health in the Workplace Mild Cognitive Impairment: Uncovering the Impact on an Ageing Workforce Cognitive Health in the Workplace Dr Jenny Barnett Director, Healthcare Innovation CANTAB Corporate Health Validated by 30 years

More information

In all of these roles, I've used healthcare data to drive strategy for the life sciences industry.

In all of these roles, I've used healthcare data to drive strategy for the life sciences industry. Intro: When you take a magnifying glass and look at a picture, you see that it's made up of thousands of dots and when you pull back, those dots become the details that create the picture. There's real

More information

A Language Modeling Approach for Temporal Information Needs

A Language Modeling Approach for Temporal Information Needs A Language Modeling Approach for Temporal Information Needs Klaus Berberich, Srikanta Bedathur Omar Alonso, Gerhard Weikum 2010, March 29th ECIR 2010 Milton Keynes Motivation Information needs having a

More information

Macmillan Cancer Support s offer to support the development of - Cancer information and support and benefits advice services for people affected by

Macmillan Cancer Support s offer to support the development of - Cancer information and support and benefits advice services for people affected by Macmillan Cancer Support s offer to support the development of - Cancer information and support and benefits advice services for people affected by cancer www.macmillan.org.uk/servicesimpact Page 1 of

More information

Application of AI in Healthcare. Alistair Erskine MD MBA Chief Informatics Officer

Application of AI in Healthcare. Alistair Erskine MD MBA Chief Informatics Officer Application of AI in Healthcare Alistair Erskine MD MBA Chief Informatics Officer 1 Overview Why AI in Healthcare topic matters Is AI just another shiny objects? Geisinger AI collaborations Categories

More information

UNDERSTANDING SQUAMOUS CELL LUNG CANCER

UNDERSTANDING SQUAMOUS CELL LUNG CANCER UNDERSTANDING SQUAMOUS CELL LUNG CANCER A guide for patients and caregivers FREE TO BREATHE SUPPORT LINE (844) 835-4325 A FREE resource for lung cancer patients & caregivers About this brochure This brochure

More information

CLINICIAN-LED E-HEALTH RECORDS. (AKA GETTING THE LITTLE DATA RIGHT) Dr Heather Leslie Ocean Informatics/openEHR Foundation

CLINICIAN-LED E-HEALTH RECORDS. (AKA GETTING THE LITTLE DATA RIGHT) Dr Heather Leslie Ocean Informatics/openEHR Foundation CLINICIAN-LED E-HEALTH RECORDS (AKA GETTING THE LITTLE DATA RIGHT) Dr Heather Leslie Ocean Informatics/openEHR Foundation An ongoing issue In attempting to arrive at the truth, I have applied everywhere

More information

Master of Business Administration: Fall 2017/Spring 2018/Fall Semesters (45 Credits)

Master of Business Administration: Fall 2017/Spring 2018/Fall Semesters (45 Credits) Master of Business Administration: Fall 2017/Spring 2018/Fall 2018-3 Semesters (45 Credits) 4 Required non-credit courses: MGMT 6010 Heroes, Leaders & Innovators (Fall) TBA MGMT 7230 Professional Development

More information

Chapter 12 Conclusions and Outlook

Chapter 12 Conclusions and Outlook Chapter 12 Conclusions and Outlook In this book research in clinical text mining from the early days in 1970 up to now (2017) has been compiled. This book provided information on paper based patient record

More information

DELIVERING OUR STRATEGY: FOR YOU, WITH YOU

DELIVERING OUR STRATEGY: FOR YOU, WITH YOU #wearenhft Northamptonshire Healthcare NHS Foundation Trust DELIVERING OUR STRATEGY: FOR YOU, WITH YOU OUR STRATEGIC PLAN: 2018-2023 01604 682682 01604 682682 nhft.nhs.uk FOR YOU, WITH YOU ABOUT NHFT We

More information

A Study of Abbreviations in Clinical Notes Hua Xu MS, MA 1, Peter D. Stetson, MD, MA 1, 2, Carol Friedman Ph.D. 1

A Study of Abbreviations in Clinical Notes Hua Xu MS, MA 1, Peter D. Stetson, MD, MA 1, 2, Carol Friedman Ph.D. 1 A Study of Abbreviations in Clinical Notes Hua Xu MS, MA 1, Peter D. Stetson, MD, MA 1, 2, Carol Friedman Ph.D. 1 1 Department of Biomedical Informatics, Columbia University, New York, NY, USA 2 Department

More information

An Interactive Guide to ALK+ Lymphoma. Our understanding of lung cancer has changed From one disease to many subtypes LCD

An Interactive Guide to ALK+ Lymphoma. Our understanding of lung cancer has changed From one disease to many subtypes LCD An Interactive Guide to ALK+ Anaplastic Lymphoma Kinase Non-Small Cell Lung (NSCLC) Our understanding of lung cancer has changed From one disease to many subtypes Click to get started Learning about Lung

More information

Shades of Certainty Working with Swedish Medical Records and the Stockholm EPR Corpus

Shades of Certainty Working with Swedish Medical Records and the Stockholm EPR Corpus Shades of Certainty Working with Swedish Medical Records and the Stockholm EPR Corpus Sumithra VELUPILLAI, Ph.D. Oslo, May 30 th 2012 Health Care Analytics and Modeling, Dept. of Computer and Systems Sciences

More information

Non-Small Cell Lung Cancer Webinar. Thursday, September 13, p.m. EDT

Non-Small Cell Lung Cancer Webinar. Thursday, September 13, p.m. EDT Non-Small Cell Lung Cancer Webinar Thursday, September 13, 2018 1 2 p.m. EDT 1 2 Webinar Faculty Julie R. Brahmer, MD Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Patrick Forde, MD Johns

More information

Personalized Treatment Approaches for Lung Cancer

Personalized Treatment Approaches for Lung Cancer Personalized Treatment Approaches for Lung Cancer California Thoracic Society 2018 Annual Carmel Conference January 27, 2018 Matthew Gubens, MD, MS Associate Professor of Medicine Chair, Thoracic Oncology

More information

Positioned for Growth

Positioned for Growth Positioned for Growth Annual Shareholders Meeting July 21, 2016 Paris Panayiotopoulos President and Chief Executive Officer David Sachs Non small cell lung cancer ARIAD clinical trial patient This presentation

More information

Regulatory Landscape for Precision Medicine

Regulatory Landscape for Precision Medicine Regulatory Landscape for Precision Medicine Adam C. Berger, Ph.D. Office of In Vitro Diagnostics and Radiological Health, FDA FOCR-Alexandria A Blueprint for Breakthrough Meeting September 13, 2017 1 What

More information

NCCN Non Small Cell Lung Cancer V Meeting July 8, 2016

NCCN Non Small Cell Lung Cancer V Meeting July 8, 2016 NSCL 3 Submission from Myriad requesting the following statement to be listed as an additional high risk factor in footnote p : For lung ADC, a highrisk 46 gene molecular prognostic score determined by

More information

MAKING DECISIONS TOGETHER. Being an Active Partner in Your Treatment and Recovery

MAKING DECISIONS TOGETHER. Being an Active Partner in Your Treatment and Recovery MAKING DECISIONS TOGETHER Being an Active Partner in Your Treatment and Recovery The Journey of Mental Health Recovery U.S. Adults Living With: Schizophrenia 10 out of 1000 Schizoaffective 2 to 5 out of

More information

Medical Treatment of Advanced Lung Cancer

Medical Treatment of Advanced Lung Cancer Medical Treatment of Advanced Lung Cancer Oncology for Scientists April 26, 2018 Edwin Yau, MD., Ph.D. Assistant Professor of Oncology Department of Medicine Department of Cancer Genetics and Genomics

More information

B I ABOUT BI DISEASE AREA & MECHANISM OF ACTION. For journalists outside UK/US/Canada only B A C K G R O U N D E R

B I ABOUT BI DISEASE AREA & MECHANISM OF ACTION. For journalists outside UK/US/Canada only B A C K G R O U N D E R For journalists outside UK/US/Canada only B I 1 4 8 2 6 9 4 1. About BI 1482694 2. Disease area & mechanism of action 3. Development status 4. Data overview 1. ABOUT BI 1482694 BI 1482694* (HM61713**)

More information

Open Research Online The Open University s repository of research publications and other research outputs

Open Research Online The Open University s repository of research publications and other research outputs Open Research Online The Open University s repository of research publications and other research outputs Toward Emotionally Accessible Massive Open Online Courses (MOOCs) Conference or Workshop Item How

More information

A Guide to Reading a Clinical or Research Publication

A Guide to Reading a Clinical or Research Publication A Guide to Reading a Clinical or Research Publication For people living with a rare disease, being able to read and understand the information found in a clinical or research publication can be especially

More information

For a legacy that lives large: Think Big. Philips CT Big Bore. Computed tomography

For a legacy that lives large: Think Big. Philips CT Big Bore. Computed tomography Computed tomography For a legacy that lives large: Think Big Philips CT Big Bore The big question The world of cancer care is rapidly changing. The number of new cancer cases is expected to rise by about

More information

TPMI Presents: Translational Genomics Research Update, Opportunities and Challenges

TPMI Presents: Translational Genomics Research Update, Opportunities and Challenges TPMI Presents: Translational Genomics Research Update, Opportunities and Challenges April 12, 2016 Darren D. O Rielly, Ph.D., FCCMG Director, Molecular Genetics Laboratory, Eastern Health Director, Translational

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Proteomic Testing for Targeted Therapy in Non-Small Cell Lung File Name: Origination: Last CAP Review: Next CAP Review: Last Review: proteomic_testing_for_targeted_therapy_in_non_small_cell_lung_cancer

More information

Experiments with CST-based Multi-document Summarization

Experiments with CST-based Multi-document Summarization Experiments with CST-based Multi-document Summarization Maria Lucia R. Castro Jorge mluciacj@icmc.usp.br Thiago A.S. Pardo taspardo@icmc.usp.br NLP Group - University of São Paulo Multi-document Summarization

More information

Cardiac CT Course Part A First step towards level 2 SCCT registration

Cardiac CT Course Part A First step towards level 2 SCCT registration 29 September 2 October 2017 Philips Customer Education Center Business Central Towers, Dubai Internet City, Sheikh Zayed Road, Dubai, UAE The use of Multi-Detector CT (MDCT) in the diagnosis of various

More information